Seven major spine and orthopedic device companies recently released quarterly financial reports.
Spinal Tech
Reportbuyer.com announced it has published a new market research report called "MediPoint: Knee Replacement — Current and Future Players," which identifies and analyzes the key companies shaping and driving the global knee replacement market.
Smith & Nephew announced the U.S. launch of its POLARSTEM cementless stem for total hip replacement.
Washington, D.C.-based George Washington University Hospital announced that it is the first healthcare facility in the U.S. to use Benvenue Medical's FDA-approved Kiva VCF Treatment System.
IMRIS announced the initial launch of the world's first Magnetic Resonance-safe and Computed Tomography-compatible horseshoe headrest for the positioning of patients during neurosurgical procedures requiring intraoperative imaging in the VISIUS Surgical Theatre.
Benvenue Medical has received 510(k) clearance from the U.S. Food and Drug Administration for its Kiva VCF system to treat vertebral compression fractures.
BioStructures announced the U.S. Food and Drug Administration has granted 510(k) clearance for Signafuse Bioactive Bone Graft Putty.
Tyber Medical announced it has formed a partnership with Magellan Capital Partners that will allow Magellan Capital Partners to provide financing services to Tyber Medical's partners.
Aurora Spine announced the first surgical implant of the company's ZIP ULTRA Minimally Invasive Interspinous Device in the United Kingdom.
Medtronic announced its total worldwide revenue for the third quarter of fiscal year 2014 is $4.163 billion, up slightly from its revenue during the same period last year, $4.027 billion.
